Cargando…

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus

INTRODUCTION: Acute and chronic insomnia can exacerbate type 2 diabetes mellitus (T2DM). We investigated suvorexant (an anti-insomnia drug that targets the orexin system) effects on sleep architecture and glucose metabolism in T2DM patients with insomnia. MATERIALS AND METHODS: This 7 day open-label...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toi, Norikazu, Inaba, Masaaki, Kurajoh, Masafumi, Morioka, Tomoaki, Hayashi, Noriyuki, Hirota, Tomoe, Miyaoka, Daichi, Emoto, Masanori, Yamada, Shinsuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306692/ https://www.ncbi.nlm.nih.gov/pubmed/30619717 http://dx.doi.org/10.1016/j.jcte.2018.12.006

Ejemplares similares

Positive association of plasma leptin with sleep quality in obese type 2 diabetes patients
por: Hirota, Tomoe, et al.
Publicado: (2018)

Effects of burosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremission tumor-induced osteomalacia initially treated with conventional therapy: Case report
por: Miyaoka, Daichi, et al.
Publicado: (2020)

Inverse association of plasma leptin with cortical thickness at distal radius determined with a quantitative ultrasound device in patients with type 2 diabetes mellitus
por: Kurajoh, Masafumi, et al.
Publicado: (2019)

Retroperitoneal Bronchogenic Cyst Adjacent to Adrenocortical Adenoma
por: Toi, Norikazu, et al.
Publicado: (2022)

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model
por: Nagata, Yuki, et al.
Publicado: (2022)

Plasma soluble leptin receptor levels are associated with pancreatic β‐cell dysfunction in patients with type 2 diabetes
por: Morioka, Tomoaki, et al.
Publicado: (2017)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
por: Nishimura, Masami, et al.
Publicado: (2019)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
por: Mori, Katsuhito, et al.
Publicado: (2012)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients
por: Toi, Norikazu, et al.
Publicado: (2019)

Association of higher arterial ketone body ratio (acetoacetate/β-hydroxybutyrate) with relevant nutritional marker in hemodialysis patients
por: Inaba, Masaaki, et al.
Publicado: (2020)

Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study
por: Kurajoh, Masafumi, et al.
Publicado: (2019)

Inflammation Related to Association of Low Uric Acid and Progression to Severe Disease in Patients Hospitalized for Non-Severe Coronavirus Disease 2019
por: Kurajoh, Masafumi, et al.
Publicado: (2023)

Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry
por: Kurajoh, Masafumi, et al.
Publicado: (2019)

Association between Poor Glycemic Control, Impaired Sleep Quality, and Increased Arterial Thickening in Type 2 Diabetic Patients
por: Yoda, Koichiro, et al.
Publicado: (2015)

Nutritional Status Association With Sarcopenia in Patients Undergoing Maintenance Hemodialysis Assessed by Nutritional Risk Index
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non‐severe coronavirus disease 2019
por: Numaguchi, Ryutaro, et al.
Publicado: (2022)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
por: Kishi, Taro, et al.
Publicado: (2019)

2420 Examining characteristics of placebo effects on trauma-related insomnia in a suvorexant trial
por: Uweh, Kimberly
Publicado: (2018)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry
por: Yoshida, Shio, et al.
Publicado: (2020)

Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients
por: Nakatani, Shinya, et al.
Publicado: (2018)

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2015)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
por: Herring, W. Joseph, et al.
Publicado: (2020)

Increased soluble IL-2 receptor levels in serum from a patient with painless thyroiditis
por: Hamamoto, Kae, et al.
Publicado: (2013)

Reduced Risk of Progression from Non-Severe to Severe COVID-19 in Hospitalized Dialysis Patients by Full COVID-19 Vaccination
por: Ichii, Mitsuru, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products Regulates Adipocyte Hypertrophy and Insulin Sensitivity in Mice: Involvement of Toll-Like Receptor 2
por: Monden, Masayo, et al.
Publicado: (2013)

Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus Who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum
por: Katayama, Hiroko, et al.
Publicado: (2015)

PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016)

Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis Patients
por: Inaba, Masaaki, et al.
Publicado: (2021)

Inter-Arm Blood Pressure Difference in Diabetes Mellitus and Its Preferential Association with Peripheral Artery Disease
por: Miyashima, Masako, et al.
Publicado: (2020)

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry
por: Kurajoh, Masafumi, et al.
Publicado: (2023)

Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial
por: Iseki, Kunitoshi, et al.
Publicado: (2022)

Is Stiffness Parameter β Useful for the Evaluation of Atherosclerosis?~ Its Clinical Implications, Limitations, and Future Perspectives ~
por: Morioka, Tomoaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aj49ejjaa5ugf1nu6qremt0nhp